BioLizard, a leader in bioinformatics, data engineering and AI-driven solutions company for life sciences, today announced it has been selected as “BioInformatics Innovation of the Year” in the fifth annual BioTech Breakthrough Awards program. The awards are administered by BioTech Breakthrough, an independent market intelligence organization that identifies and honors the top companies, technologies, and products shaping biotechnology today.

BioLizard was selected for its innovative Bio|Verse platform, and in particular Bio|Verse Navigator, a powerful visual analytics workspace that helps organizations make sense of their most complex research data. Bio|Verse brings information together in one place, giving scientists a clear and intuitive view of their projects so they can make faster, more confident decisions.

Behind Bio|Verse Navigator sits Bio|Verse’s data orchestration layer, which organizes and connects data from multiple sources into one consistent, reliable environment. This foundation helps research teams work more efficiently, reduces data silos, and ensures that information is traceable, well-structured, and ready for analysis.

Built on top of this core layer, BioLizard offers a range of optional applications that support common R&D needs—such as exploring biological mechanisms, identifying potential biomarkers, or comparing results across studies. These applications allow organizations to quickly add the capabilities they need without building new tools themselves.

Bio|Verse, is the foundation of BioLizard’s tech-enabled services: a hybrid model that combines advanced technology with hands-on scientific and data expertise. This approach ensures clients receive not only powerful tools but also clear guidance and tailored support to turn their data into meaningful insights.

“We are proud to receive the ‘Bioinformatics Innovation of the Year’ award from BioTech Breakthrough,” said Liesbeth Ceelen, CEO of BioLizard. “Our mission is to push the boundaries of what is scientifically possible with data. With Bio|Verse, we help organizations transform complex information into clarity and actionable insight. What truly sets us apart is our commitment to tech-enabled services and bringing together our platform and our expert team to deliver solutions that are transparent, collaborative, and impactful.”

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and helped integrate research, clinical, and real-world data to improve therapeutic decision-making across biotech, pharmaceutical, diagnostic, and academic partners.

“BioLizard is delivering the clarity and innovation needed to advance modern R&D,” said Bryan Vaughn, Managing Director of BioTech Breakthrough. “Data complexity is one of the greatest challenges in life sciences today. BioLizard’s approach in bringing data together, making it easier to understand, and supporting it with expert guidance which represents the future of bioinformatics. Their work is helping companies accelerate development, reduce costs, and bring life-changing solutions to patients more quickly.”